ALVEOLAR RHABDOMYOSARCOMA

ALVEOLAR RHABDOMYOSARCOMA was reported 44 times

These drug classes are most commonly taken by patients reporting ALVEOLAR RHABDOMYOSARCOMA:

# Drug Count
0 Alkylating Drug [EPC] 17
1 Nonsteroidal Anti-inflammatory Drug [EPC] 10
2 Topoisomerase Inhibitor [EPC] 10
3 Kinase Inhibitor [EPC] 6
4 Actinomycin [EPC] 4
5 Recombinant Human Growth Hormone [EPC] 4
6 Benzodiazepine [EPC] 3
7 Anti-epileptic Agent [EPC] 2
8 Central alpha-2 Adrenergic Agonist [EPC] 2
9 Corticosteroid [EPC] 2
10 Folate Analog Metabolic Inhibitor [EPC] 2
11 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
12 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
13 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
14 Interferon beta [EPC] 2
15 Mood Stabilizer [EPC] 2
16 Nucleoside Metabolic Inhibitor [EPC] 2
17 Osmotic Laxative [EPC] 2
18 Platinum-based Drug [EPC] 2
19 5-alpha Reductase Inhibitor [EPC] 1
20 Amide Local Anesthetic [EPC] 1
21 Antiarrhythmic [EPC] 1
22 Azole Antifungal [EPC] 1
23 BCL-2 Inhibitor [EPC] 1
24 Cholinergic Muscarinic Antagonist [EPC] 1
25 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
26 Ester Local Anesthetic [EPC] 1
27 Estrogen [EPC] 1
28 GLP-2 Analog [EPC] 1
29 Histamine-1 Receptor Antagonist [EPC] 1
30 Leukocyte Growth Factor [EPC] 1
31 Nitrogen Binding Agent [EPC] 1
32 Non-Standardized Chemical Allergen [EPC] 1
33 Opioid Agonist [EPC] 1
34 Penem Antibacterial [EPC] 1
35 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
36 Progestin [EPC] 1
37 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
38 Provitamin D2 Compound [EPC] 1
39 RANK Ligand Inhibitor [EPC] 1
40 Serotonin-3 Receptor Antagonist [EPC] 1
41 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
42 Vitamin C [EPC] 1
43 mTOR Inhibitor Immunosuppressant [EPC] 1